Pfizer to pay $68 billion for Wyeth
Pfizer Inc. will pay about $68 billion for Madison-based Wyeth, the two pharmaceutical companies announced today.
Pharmaceutical giant Pfizer Inc. says it is buying rival drugmaker Wyeth in a US$68 billion cash-and-stock deal that could reshape the drug development industry.